Augmentation of therapeutic potential of curcumin using nanotechnology: current perspectives
- 28 February 2018
- journal article
- research article
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 46 (sup1) , 1004-1015
Abstract
Curcumin, an active principle of Curcuma longa, is extracted from the rhizome. Its therapeutic efficiency has been proved using various in vitro and in vivo models. Inflammatory, neoplastic and preneoplastic diseases are the major targets using curcumin as therapeutic agent. Feasible clinical formulations could not be obtained because of its lack of solubility, stability and higher degradation rate. Recently, many techniques have been evolved to improve the physicochemical properties of pharmacological compounds, thereby increasing their biological activity. Curcumin has been developed using various techniques, particularly micro and nanotechnology to improve its stability and bioavailability. This review focuses on the studies pertaining to the delivery of curcumin in the form of micro and nanosize formulations for the treatment of a variety of diseases.Keywords
This publication has 109 references indexed in Scilit:
- A new method for pH triggered curcumin release by applying poly(l-lysine) mediated nanoparticle-congregationAnalytica Chimica Acta, 2013
- Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applicationsInternational Journal of Nanomedicine, 2012
- Curcumin nanodisks: formulation and characterizationNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Nanosized magnetofluorescent Fe3O4–curcumin conjugate for multimodal monitoring and drug targetingColloids and Surfaces A: Physicochemical and Engineering Aspects, 2010
- Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growthJournal of Ovarian Research, 2010
- The dark side of curcuminInternational Journal of Cancer, 2010
- Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelatorBlood, 2009
- Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapyJournal of Nanobiotechnology, 2007
- Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-ActivationPPAR Research, 2007
- Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcuminJournal of Pharmaceutical and Biomedical Analysis, 2006